{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T06:21:19Z","timestamp":1771482079867,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T00:00:00Z","timestamp":1592611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T00:00:00Z","timestamp":1592611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00296-020-04631-3","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T20:12:39Z","timestamp":1592683959000},"page":"1283-1290","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Demographic and clinical characteristics of patients with ANCA-positive vasculitis in a Colombian University Hospital over a 12-year period: 2005\u20132017"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1490-1822","authenticated-orcid":false,"given":"Daniel G.","family":"Fern\u00e1ndez-\u00c1vila","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9804-8990","authenticated-orcid":false,"given":"Juli\u00e1n","family":"Rond\u00f3n-Carvajal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7865-4643","authenticated-orcid":false,"given":"Catalina","family":"Villota-Eraso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8549-661X","authenticated-orcid":false,"given":"Juan Mart\u00edn","family":"Guti\u00e9rrez-D\u00e1vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8892-9652","authenticated-orcid":false,"given":"Kateir Mariel","family":"Contreras-Villamizar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,20]]},"reference":[{"issue":"3","key":"4631_CR1","first-page":"248","volume":"16","author":"CD Ochoa","year":"2009","unstructured":"Ochoa CD, Ram\u00edrez F, Quintana G, Toro C, Ca\u00f1as C, Osio LF et al (2009) Epidemiology of primary vasculitis in Colombia and its relation with reported for latin america. Rev Colomb Reumatol 16(3):248\u2013263","journal-title":"Rev Colomb Reumatol"},{"key":"4631_CR2","doi-asserted-by":"crossref","unstructured":"Pomares Quimbaya A, Gonzalez RA, Mu\u00f1oz O, Garc\u00eda OM, Bohorquez WR (2017) A strategy for prioritizing electronic medical records using structured analysis and natural language processing. Ing y Univ [Internet] 22(1):7\u201331. https:\/\/revistas.javeriana.edu.co\/index.php\/iyu\/article\/view\/17809","DOI":"10.11144\/Javeriana.iyu22-1.spem"},{"key":"4631_CR3","doi-asserted-by":"crossref","unstructured":"Azaola AH, Alvarez CAN (2016) Anti-neutrophil cytoplasmic antibody-associated vasculitis in Mexican population: clinical phenotype, autoantibody profile and renal characteristics. J Vasc [Internet] 2(2) https:\/\/www.omicsonline.org\/open-access\/antineutrophil-cytoplasmic-antibody-associated-vasculitis-in-mexicanpopulation-clinical-phenotype-autoantibody-profile-and-renal-ch-2471-9544-100110.php?aid=75935","DOI":"10.4172\/2471-9544.100110"},{"key":"4631_CR4","doi-asserted-by":"crossref","unstructured":"Solans-Laqu\u00e9 R, Fraile G, Rodriguez-Carballeira M, Caminal L, Castillo MJ, Mart\u00ednez-Valle F, et al. (2017) Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity. Medicine (Baltimore) [Internet] 96(8):e6083. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28225490","DOI":"10.1097\/MD.0000000000006083"},{"key":"4631_CR5","doi-asserted-by":"crossref","unstructured":"W\u00f3jcik K, Wawrzycka-Adamczyk K, W\u0142udarczyk A, Sznajd J, Zdrojewski Z, Masiak A, et al. (2019) Clinical characteristics of Polish patients with ANCA-associated vasculitides\u2014retrospective analysis of POLVAS registry. Clin Rheumatol [Internet] https:\/\/link.springer.com\/10.1007\/s10067-019-04538-w","DOI":"10.1007\/s10067-019-04538-w"},{"key":"4631_CR6","doi-asserted-by":"crossref","unstructured":"Sada K, Yamamura M, Harigai M, Fujii T, Dobashi H, Takasaki Y, et al. (2014) Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study. Arthritis Res Ther [Internet] 16(2):R101. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24758294","DOI":"10.1186\/ar4550"},{"key":"4631_CR7","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. (2013) 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum [Internet] 65(1):1\u201311. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23045170"},{"key":"4631_CR8","doi-asserted-by":"crossref","unstructured":"Yumura W, Kobayashi S, Suka M, Hayashi T, Ito S, Nagafuchi H, et al. (2014) Assessment of the Birmingham vasculitis activity score in patients with MPO-ANCA-associated vasculitis: sub-analysis from a study by the Japanese Study Group for MPO-ANCA-associated vasculitis. Mod Rheumatol [Internet] 24(2):304\u20139. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24593206","DOI":"10.3109\/14397595.2013.854075"},{"key":"4631_CR9","doi-asserted-by":"crossref","unstructured":"Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Le Toumelin P, et al. (2011) The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore) [Internet] 90(1):19\u201327. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21200183","DOI":"10.1097\/MD.0b013e318205a4c6"},{"key":"4631_CR10","unstructured":"(2018) Epidemiology is a science of high importance. Nat Commun [Internet] 9(1):1703. https:\/\/www.nature.com\/articles\/s41467-018-04243-3"},{"key":"4631_CR11","doi-asserted-by":"crossref","unstructured":"Scott DGI, Watts RA (2013) Epidemiology and clinical features of systemic vasculitis. Clin Exp Nephrol [Internet] 17(5):607\u201310. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23843034","DOI":"10.1007\/s10157-013-0830-8"},{"key":"4631_CR12","doi-asserted-by":"crossref","unstructured":"Yamagata K, Usui J, Saito C, Yamaguchi N, Hirayama K, Mase K, et al. (2012) ANCA-associated systemic vasculitis in Japan: clinical features and prognostic changes. Clin Exp Nephrol [Internet] 16(4):580\u20138. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22350463","DOI":"10.1007\/s10157-012-0598-2"},{"key":"4631_CR13","doi-asserted-by":"crossref","unstructured":"Lionaki S, Blyth ER, Hogan SL, Hu Y, Senior BA, Jennette CE, et al. (2012) Classification of antineutrophil cytoplasmic autoantibody vasculitides: The role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum [Internet] 64(10):3452\u201362. https:\/\/doi.wiley.com\/10.1002\/art.34562","DOI":"10.1002\/art.34562"},{"key":"4631_CR14","doi-asserted-by":"crossref","unstructured":"Tan JA, Dehghan N, Chen W, Xie H, Esdaile JM, Avina-Zubieta JA (2017) Mortality in ANCA-associated vasculitis: ameta-analysis of observational studies. Ann Rheum Dis [Internet] 76(9):1566\u201374. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28468793","DOI":"10.1136\/annrheumdis-2016-210942"},{"key":"4631_CR15","doi-asserted-by":"crossref","unstructured":"Chaudhry R, Bilal A, Austin A, Mehta S, Salman L, Foulke L, et al. (2007) EULAR recommendations for conducting clinical studies and\/or clinical trials in systemic vasculitis: Focus on anti-neutrophil cytoplasm antibody-associated vasculitis. J Bras Nefrol [Internet] 66(5):605\u201317. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30095143","DOI":"10.1136\/ard.2006.062711"},{"key":"4631_CR16","unstructured":"Poulton CJ, Nachman PH, Hu Y, McGregor JG, Jennette JC, Falk RJ, et al. (2013) Pathways to renal biopsy and diagnosis among patients with ANCA small-vessel vasculitis. Clin Exp Rheumatol [Internet] 31(1 Suppl 75):S32\u20137. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23343774"},{"key":"4631_CR17","doi-asserted-by":"crossref","unstructured":"Pagnoux C (2016) Updates in ANCA-associated vasculitis. Eur J Rheumatol [Internet] 3(3):122\u201333. https:\/\/www.eurjrheumatol.org\/sayilar\/207\/buyuk\/122-133.pdf","DOI":"10.5152\/eurjrheum.2015.0043"},{"key":"4631_CR18","doi-asserted-by":"crossref","unstructured":"Jennette JC, Nachman PH (2017) ANCA Glomerulonephritis and Vasculitis. Clin J Am Soc Nephrol [Internet] 12(10):1680\u201391. https:\/\/cjasn.asnjournals.org\/lookup\/doi\/10.2215\/CJN.02500317","DOI":"10.2215\/CJN.02500317"},{"key":"4631_CR19","doi-asserted-by":"crossref","unstructured":"Lepeytre F, Royal V, Lavoie P-L, Boll\u00e9e G, Gougeon F, Beauchemin S, et al. (2019) Estimating the change in renal function during the first year of therapy in ANCA-associated vasculitis. Kidney Int Rep [Internet] 4(4):594\u2013602. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30993234","DOI":"10.1016\/j.ekir.2019.02.005"},{"key":"4631_CR20","doi-asserted-by":"crossref","unstructured":"Walsh M, Merkel PA, Peh CA, Szpirt W, Guillevin L, Pusey CD, et al. (2013) Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial. Trials [Internet] 14(1):73. https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-14-73","DOI":"10.1186\/1745-6215-14-73"},{"key":"4631_CR21","doi-asserted-by":"crossref","unstructured":"Dadonien\u0117 J, Kum\u017eait\u0117 G, Ma\u010diulyt\u0117 R, Miltinien\u0117 D (2017) Clinical characteristics and long-term survival differences of the ANCA-associated vasculitis group: a cross-sectional study of 27 patients. Acta Medica Litu [Internet] 24(2):107\u201312. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28845128","DOI":"10.6001\/actamedica.v24i2.3491"},{"key":"4631_CR22","doi-asserted-by":"publisher","unstructured":"Salmela A, T\u00f6rnroth T, Poussa T, Ekstrand A (2018) Clinical Study Prognostic Factors for Survival and Relapse in ANCA-Associated Vasculitis with Renal Involvement: A Clinical Long-Term Follow-Up Study. Int J Nephrol [Internet]. https:\/\/doi.org\/10.1155\/2018\/6369814","DOI":"10.1155\/2018\/6369814"},{"key":"4631_CR23","unstructured":"Chaudhry R, Bilal A, Austin A, Mehta S, Salman L, Foulke L, et al. (2018) ANCA associated vasculitis: experience of a tertiary care referral center. Brazilian J Nephrol [Internet]. https:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0101-28002018005024102&lng=en&tlng=en"},{"key":"4631_CR24","doi-asserted-by":"crossref","unstructured":"Wu C-S, Hsieh C-J, Peng Y-S, Chang T-H, Wu Z-Y (2015) Antineutrophil cytoplasmic antibody-associated vasculitis in Taiwan: a hospital-based study with reference to the population-based National Health Insurance database. J Microbiol Immunol Infect [Internet] 48(5):477\u201382. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24560699","DOI":"10.1016\/j.jmii.2013.12.006"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04631-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-020-04631-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04631-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T16:41:28Z","timestamp":1659112888000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-020-04631-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,20]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["4631"],"URL":"https:\/\/doi.org\/10.1007\/s00296-020-04631-3","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,20]]},"assertion":[{"value":"15 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None of the authors declare that they have conflict of interest in relation to this manuscript","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}